FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100954 [Registered on: 13/01/2026] Trial Registered Prospectively
Last Modified On: 13/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To evaluate the drug efficacy of lashunadi vati in udavartini yonivyapad with special reference to Primary dysmenorrhoea  
Scientific Title of Study   Randomized Controlled Clinical Study To Evaluate The Efficacy Of Lashunadi Vati In The Management Of Udavartini Yonivyapad With Special Reference To Primary Dysmenorrhoea 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shivani Ravindra Tuptewar 
Designation  PG Scholar 
Affiliation  Siddhakala Ayurveda college and research center sangamner 
Address  Ground floor OPD No 5 , Streeroga Avum Prasutitantra Department , Siddhakala Ayurved Mahavidyalaya , Pimparane Road , Sangamner Khurd , Sangamner , Ahilyanagar , Maharashtra , 422605
Ground floor OPD No 5 , Streeroga Avum Prasutitantra Department , Siddhakala Ayurved Mahavidyalaya , Pimparane Road , Sangamner Khurd , Sangamner , Ahilyanagar , Maharashtra , 422605
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  7218781199  
Fax    
Email  shivanituptewar2000@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vipul Vishwanath Bhujbal 
Designation  HOD Of Streeroga Avum Prasutitantra 
Affiliation  Siddhakala Ayurveda College and Research Center Sangamner 
Address  Ground floor OPD No 5 , Streeroga Avum Prasutitantra Department , Siddhakala Ayurved Mahavidyalaya , Pimparane Road , Sangamner Khurd , Sangamner , Ahilyanagar , Maharashtra , 422605
Ground floor OPD No 5 , Streeroga Avum Prasutitantra Department , Siddhakala Ayurved Mahavidyalaya , Pimparane Road , Sangamner Khurd , Sangamner , Ahilyanagar , Maharashtra , 422605
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9960840214  
Fax    
Email  vipulbhujbal1@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Shivani Ravindra Tuptewar 
Designation  PG Scholar 
Affiliation  Siddhakala Ayurveda college and Research Center Sangamner 
Address  Ground floor OPD No 5 , Streeroga Avum Prasutitantra Department , Siddhakala Ayurved Mahavidyalaya , Pimparane Road , Sangamner Khurd , Sangamner , Ahilyanagar , Maharashtra , 422605
Ground floor OPD No 5 , Streeroga Avum Prasutitantra Department , Siddhakala Ayurved Mahavidyalaya , Pimparane Road , Sangamner Khurd , Sangamner , Ahilyanagar , Maharashtra , 422605
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  7218781199  
Fax    
Email  shivanituptewar2000@gmail.com  
 
Source of Monetary or Material Support  
Siddhakala Ayurved Mahavidyalaya , Pimparane Road , Sangamner Khurd , Sangamner, Ahilyanagar , Maharashtra, India , Pincode - 422605 
 
Primary Sponsor  
Name  Dr Shivani Ravindra Tuptewar 
Address  Siddhakala Ayurved Mahavidyalaya , Pimparane Road , Sangamner Khurd , Sangamner, Ahilyanagar , Maharashtra, India , Pincode - 422605 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shivani Ravindra Tuptewar  Siddhakala Ayurveda Mahavidyalay And Hospital,Pimparne Road, Sangmaner  Ground floor OPD No 5 , Streeroga Avum Prasutitantra Department , Siddhakala Ayurved Mahavidyalaya , Pimparane Road , Sangamner Khurd , Sangamner , Ahilyanagar , Maharashtra , 422605
Ahmadnagar
MAHARASHTRA 
7218781199

shivanituptewar2000@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Board Of Research And Statistics Committee Of Siddhakala Ayurved Mahavidyalaya , Sangamner  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: UDAVARTINI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Rajapravartini Vati, Reference: Bhaishajya ratnavali , Yonivyapad Chikitsa Adhyay , Chapter No-58 , Shloka No- 59, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Koshna Jal), Additional Information: Rajapravartini Vati 250 mg BD Early Morning And Evening Before Meal With Koshna jal for Three Consecutive Menstrual Cycles.
2Intervention ArmDrugClassical(1) Medicine Name: Lashunadi vati , Reference: Vaidyajeevan, Lolimbraj, Chaturth vilas,Kshayadigadanam chikitsa adhyay, Shloka no 13, Page no. 97, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -koshna jala), Additional Information: - Early Morning and Evening before meal for three consecutive menstrual cycles
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  25.00 Year(s)
Gender  Female 
Details  1.Patients on hormonal therapy.
2.Pelvic Inflammatory Disease, uterine fibroid, Adenomyosis.
3.Known case of structural anomalies of genital tract.
4.Known case of immune compressive diseases like HIV, HBsAg. 
 
ExclusionCriteria 
Details  1. Patients on hormonal therapy.
2. Pelvic Inflammatory Disease, uterine fibroid, Adenomyosis.
3. Known case of structural anomalies of genital tract.
4. Known case of immune compressive diseases like HIV , HBsAg.
5. Known case of life style disorders like DM, HTN, PCOD, Thyroid
abnormalities 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study in detail the rate and extent of pain relief after the oral administration of Lashunadi vati 250mg BD for consecutive 3 menstrual cycles.  3 months  
 
Secondary Outcome  
Outcome  TimePoints 
-To assess any adverse reaction or side effect related to the oral administration of Lashunadi vati.
-To introduce effective ayurvedic medicine for Udavartini yonivyapad. 
3 months  
 
Target Sample Size   Total Sample Size="110"
Sample Size from India="110" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   10/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This Study is Randomized Open Labelled Controlled Clinical Trial Comparing  the Safety and Efficacy of Lashunadi Vati 250 mg BD With Koshna Jal Before Meal And Controlled Drug Rajapravartini Vati 250 mg BD With Koshna Jal Before Meal For 3 Consecutive Menstrual Cycles in 110 Patient of Udavartini Yonivyapad Divided In 2 Groups And Observed VAS NRS Scale. 
Close